Pinealon (EDR tripeptide) is a synthetic short?chain bioregulatory tripeptide, originally developed for pineal gland and central nervous system related pre?clinical research. It consists of three amino?acid residues: Glutamic acid, Aspartic acid and Arginine. Due to its small molecular size, it can cross biological barriers in animal models and participates in neuroprotection, oxidative stress mitigation, neuronal survival and gene?expression?related exploratory studies.
This peptide is widely used in neuroscience laboratory projects, including anti?oxidative stress assays, neuronal anti?apoptosis experiments, brain aging mechanism research, circadian rhythm exploration and in?vitro & in?vivo central nervous system model tests. It serves as an important research tool for studying peptide bioregulators of nervous tissue.
Our Pinealon tripeptide is manufactured by solid?phase peptide synthesis. Each batch is strictly analyzed by HPLC and mass spectrometry to confirm high purity and accurate molecular sequence. COA document is available upon customer request. Lyophilized powder form ensures good stability during transportation and long?term preservation. Multiple packaging specifications are supported, ranging from small laboratory sample vials to bulk kilogram?level orders.